Account
Inquiry
Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This innovative compound demonstrates superior efficacy in glucose control and weight reduction compared to single agonists.
Our pharmaceutical-grade Tirzepatide features 99.9% purity and is specially packaged for research applications. The compound's unique molecular structure includes PEG modification on the lys side chain, enhancing water solubility while maintaining biological activity.
Clinical studies indicate Tirzepatide's significant weight loss potential, with trial participants achieving 15-20.9% body weight reduction over 72 weeks. The compound has received FDA Fast Track designation for obesity-related research applications.
For researchers wondering where to buy tirzepatide, we offer bulk quantities with flexible packaging options. Our standard configuration includes 10mg/vial with 10 vials per box, suitable for various research protocols.
The peptide works through dual mechanisms: GIP receptor activation enhances insulin secretion while GLP-1 receptor agonism promotes satiety and slows gastric emptying. This combined action makes Tirzepatide particularly effective for metabolic research.
Proper storage is essential for maintaining peptide integrity. We recommend keeping Tirzepatide in a cool, dark environment and avoiding repeated freeze-thaw cycles. For long-term stability, aliquot according to experimental requirements.
Researchers looking where to buy tirzepatide can rely on our consistent quality and purity standards. Each batch undergoes rigorous testing to ensure pharmaceutical-grade specifications are met.
Note: This product is intended for research purposes only. Not for human consumption or diagnostic use. Please handle all research compounds with appropriate safety precautions.
